IL6 and acute myeloid leukemia: The proportions of TH17-like cells to total T/NK lymphocytes in most AML patients are much more than healthy individuals, whatever before or after treatment (Fig. 4c, Supplementary Figure 4A), which is positively correlated with increasing IL6 secreted from malignant cells [7].